Implications of 'cell kill' for the treatment of acute myelogenous leukemia: can the cure rate be increased?
Arlin
Z A
ZA
New York Medical College, Valhalla, N.Y.
Hagenbeek
A
A
Feldman
E J
EJ
Andreeff
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002470:Cell Survival / Q000187:drug effects; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D012074:Remission Induction